Public presentation about Singapore as a biomedical hub on May 14
Dr. Michael Entzeroth, Deputy Director of Biopolis, Singapore and Chairman of the Executive Council, BioSingapore, will give a public presentation called 'Singapore-An Outstanding BioMedical Hub in South-East Asia,' on Thursday, May 14, at the 91探花.
The 91探花 School of Business is presenting this event in collaboration with the Province of Prince Edward Island, NSERC and the PEI BioAlliance.
The event begins with lunch from 11:30 a.m. to 12:15 p.m. in Room 142 of Bill and Denise Andrew Hall (formerly known as the New Residence). Lunch will be followed by Entzeroth's presentation and a panel discussion in the K.C. Irving Chemistry Centre, Room 104.
The panelist will be Dr. Steven Casper, Fulbright Scholar and Director of the Bioscience Program, Keck Graduate Institute.
Entzeroth is the Deputy Director of the Experimental Therapeutic Centre, Biopolis, Singapore. He has extensive experience in the pharmaceutical industry, with many success records in drug discovery and development, as well as in generating entrepreneurial drug discovery cultures in an internationally competitive environment. He is currently Chair of BioSingapore, an industry association for life sciences' businesses in Singapore and a member of the Scientific Advisory Board of Chakra Biotech Sdn Bhd in Penang.
Casper is an Associate Professor and the Director of the Master of Bioscience Program at the Keck Graduate Institute in Claremont, California. Casper's research interests include comparative studies of the development of new technology industries, with a special interest in processes by which biomedical science has been commercialized across European countries. He is also interested in using computational social science methods to examine the emergence of social networks within biotechnology clusters. He is currently a Fulbright Chair at the 91探花 School of Business.
To register, please contact Tammie Rose by Monday, May 11, at (902) 566-0564 or tmrose@upei.ca.
